Acumen Pharmaceuticals, Inc.
ABOSNASDAQ
Healthcare
Biotechnology
$2.70
+0.15(5.9%)
52W $0.90 – $3.37
Quick:
8-K
Mar 26, 2026 (1 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Mar 16, 2026 (3 weeks ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jan 12, 2026 (2 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Nov 12, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 12, 2025 (4 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Nov 10, 2025 (4 months ago)Current Report
Material event disclosure
Event materiality and market reaction
SCHEDULE 13G/A
Nov 4, 2025 (5 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
SCHEDULE 13G/A
Aug 13, 2025 (7 months ago)Beneficial Ownership (Amendment)
Large shareholder position disclosure
Ownership threshold, passive vs active
10-Q
Aug 12, 2025 (7 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
8-K
Aug 12, 2025 (7 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jul 15, 2025 (8 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
Jun 5, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
8-K
May 13, 2025 (10 months ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
May 13, 2025 (10 months ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
SCHEDULE 13D/A
Mar 31, 2025 (1 years ago)SCHEDULE 13D/A (Amendment)
SEC filing disclosure
Filing details and context
8-K
Mar 27, 2025 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction
10-K
Mar 27, 2025 (1 years ago)Annual Report
Full-year financial statements and risk factors
YoY revenue/margin trends, new risk disclosures
8-K
Nov 12, 2024 (1 years ago)Current Report
Material event disclosure
Event materiality and market reaction
10-Q
Nov 12, 2024 (1 years ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes
10-Q
Aug 13, 2024 (1 years ago)Quarterly Report
Quarterly financial update
Sequential growth, guidance changes